NCT05151523Not yet recruiting
Long-term Recurrence Rates of Atrial Fibrillation Following New-onset Atrial Fibrillation During ICU Admission
Source: ClinicalTrials.gov · Last updated 16 Dec 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Primary Objective of the study is to establish the One-year recurrence rates of atrial fibrillation (AF) following new-onset atrial fibrillation during intensive care unit (ICU) admission. The Secondary Objective is a composite of death from cardiovascular causes, stroke (either ischemic or hemorrhagic), or hospitalization with worsening of heart failure or recurrent AF. The prevalence and recurrence rates of AF will be divided into sub-groups based on primary ICU admission diagnosis. All-cause mortality.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 3 Nov 2021
- Start date
- 1 Jan 2022
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Katia Orvin
- Diseases
- Atrial fibrillation
- NCT number
- NCT05151523
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jan 2022 to the primary completion date, 1 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously documented atrial fibrillation
Who the study is looking for
- Admitted to ICU over 24 hours
- Diagnosed with new-onset atrial fibrillation
- The patient survived the index hospitalization and was discharged home/ to a rehabilitation center.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.